Dr. Temel Discusses Her Work on Anamorelin for Treating NSCLC Patients with Anorexia and Cachexia

At ESMO 2014, Dr Jennifer Temel is interviewed about the results of a phase III trial investigating the use of anamorelin in NSCLC patients with anorexia and cachexia. She discusses the next steps for anamorelin with a focus on regulatory approval and impact in clinical practice.

Year of Production:
Running Time:
Color/Sound:

2014
03:56
Color/Sound

Comments are closed.